Corazon (corsee) D. Sanders
Corazon (corsee) D. Sanders's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares…
Insider buying and selling since 2023
Corazon (corsee) D. Sanders has no open-market purchase on record since 2023 across 3 companies. Sales in each of the last 4 years.
Corazon (corsee) D. Sanders reported 0 open-market purchases and 9 sales since 2023; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | 1×1 trade |
| 2025 | — | 2×2 trades |
| 2024 | — | 2×2 trades |
| 2023 | — | 4×4 trades |
Insider at 3 companies
- Legend Biotech LEGN2026 · 0 purchases, 1 sale
- Ultragenyx Pharmaceutical RARE2023–2025 · 0 purchases, 5 sales
- Beone Medicines ONC2023–2025 · 0 purchases, 3 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Corazon (corsee) D. Sanders's trades
Has Corazon (corsee) D. Sanders bought shares on the open market?
Corazon (corsee) D. Sanders has no open-market purchase on record since 2023 across 3 companies. Sales in each of the last 4 years.
When did Corazon (corsee) D. Sanders last buy or sell shares?
In SEC filings since 2023: no open-market purchase is on record; the latest open-market sale is from 2026.
Which companies has Corazon (corsee) D. Sanders traded as an insider?
3 companies: Legend Biotech (LEGN, 2026), Ultragenyx Pharmaceutical (RARE, 2023–2025), Beone Medicines (ONC, 2023–2025).